Literature DB >> 16024900

Is dementia reversible in patients with neurocysticercosis?

J Ramirez-Bermudez1, J Higuera, A L Sosa, E Lopez-Meza, M Lopez-Gomez, T Corona.   

Abstract

OBJECTIVE: To determine the correlates and outcome of dementia in patients with neurocysticercosis (NCC).
METHODS: Ninety consecutive patients with untreated NCC underwent a cognitive assessment (Mini-mental State Examination, Neurobehavioral Cognitive Status Examination, and IQCODE) and were classified as having or not having dementia according to DSM-IV criteria. Imaging and cerebrospinal fluid examination data were recorded. The cognitive measures were repeated six months after treatment with albendazole and steroids.
RESULTS: At the initial evaluation 15.5% (n = 14) of the patients were classified as having dementia. Dementia was associated with older age, lower education level, increased number of parasitic lesions in the brain (mostly in the frontal, temporal, and parietal lobes). After six months, 21.5% of the patients from the dementia group continued to have a full dementia disorder and 78.5% no longer fulfilled the DSM-IV criteria for dementia, although some of these patients still showed mild cognitive decline.
CONCLUSIONS: The results of this study suggest that dementia occurs frequently in patients with untreated NCC, and it is reversible in most cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024900      PMCID: PMC1739738          DOI: 10.1136/jnnp.2004.052126

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Is the presence of depression independent from signs of disease activity in patients with neurocysticercosis?

Authors:  Sergio Monteiro de Almeida; Solange Aparecida Gurjão
Journal:  J Community Health       Date:  2011-10

Review 2.  Omental transplantation for neurodegenerative diseases.

Authors:  Hernando Rafael
Journal:  Am J Neurodegener Dis       Date:  2014-09-06

3.  An Unusual Presentation of Neurocysticercosis: A Space-Occupying Lesion in the Fourth Ventricle Associated with Progressive Cognitive Decline.

Authors:  Carolin Kurz; Veronika Schmidt; Holger Poppert; Patricia Wilkins; John Noh; Sven Poppert; Jürgen Schlegel; Claire Delbridge; Clarissa Prazeres da Costa; Andrea S Winkler
Journal:  Am J Trop Med Hyg       Date:  2015-11-30       Impact factor: 2.345

4.  Quality of life assessment in patients with neurocysticercosis.

Authors:  Sergio Monteiro de Almeida; Solange Aparecida Gurjão
Journal:  J Community Health       Date:  2011-08

Review 5.  Extraparenchymal (Racemose) Neurocysticercosis and Its Multitude Manifestations: A Comprehensive Review.

Authors:  Rohan R Mahale; Anish Mehta; Srinivasa Rangasetty
Journal:  J Clin Neurol       Date:  2015-05-28       Impact factor: 3.077

Review 6.  Neurocysticercosis: current knowledge and advances.

Authors:  Wayne X Shandera; Joseph S Kass
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

7.  Cognitive changes and quality of life in neurocysticercosis: a longitudinal study.

Authors:  Mitchell T Wallin; E Javier Pretell; Javier A Bustos; Marianella Caballero; Mercedes Alfaro; Robert Kane; Jeffrey Wilken; Cynthia Sullivan; Timothy Fratto; Hector H Garcia
Journal:  PLoS Negl Trop Dis       Date:  2012-01-31

8.  Reversible dementia as a presenting manifestation of racemose neurocysticercosis.

Authors:  Sudhir Sharma; Manish Modi; Vivek Lal; Sudesh Prabhakar; Amit Bhardwaj; Rakesh Sehgal
Journal:  Ann Indian Acad Neurol       Date:  2013-01       Impact factor: 1.383

9.  A study of neuropsychiatric manifestations in patients of neurocysticercosis.

Authors:  Smita Srivastava; Rakesh Kumar Chadda; Kiran Bala; Pradipta Majumdar
Journal:  Indian J Psychiatry       Date:  2013-07       Impact factor: 1.759

10.  Cognitive Dysfunction and its Determinants in Patients with Neurocysticercosis.

Authors:  Vinod Varghese; Sadanandavalli Retnaswami Chandra; Rita Christopher; Jamuna Rajeswaran; Chandrajit Prasad; R Subasree; Thomas Gregor Issac
Journal:  Indian J Psychol Med       Date:  2016 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.